ArticleCJC open2026

Very Late-Onset Cancer Therapy-Related Cardiac Dysfunction After More Than 100 Courses of Anti-HER2-Based Therapy for Breast Cancer.

Masayuki Kikuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.